Growth Potential DiaPharma operates in a niche biotechnology space with annual revenue between 10M and 25M and a staff of 11-50, indicating room for expansion through broadened product offerings in thrombosis, haemostasis, liver disease, and metabolic disease testing.

Product Expansion Current portfolio includes test kits, reagents, and instruments; cross-sell opportunities exist by pairing instruments with complementary reagents and kits across platelet function analysis, apoptosis, and metabolic disease workflows.

Academic & Events Active participation in ISLH conferences and a history of hiring specialized scientific staff suggests value in partnerships for co-branded education, researcher-focused demos, and early access programs for new assays.

Digital & E‑commerce Tech stack shows emphasis on e-commerce and CRM (Shopify, WooCommerce, Salesforce) with WordPress and Google Cloud, enabling targeted digital campaigns, B2B lead nurturing, and streamlined purchasing for lab buyers.

Sales Outreach Recent hires in business development and a dedicated customer service team point to a sales motion that can scale with structured account-based outreach, clinical collaboration opportunities, and high-touch post-sale support for repeat orders.